Two Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59%

Summary

Article discusses two drugmakers that collectively control 90% of the obesity drug market and mentions a fund holding both companies with a 0.59% allocation. Insufficient detail provided to extract specific drug names, financial data, or catalysts.